A study has found that aficamten is associated with improvements across a range of clinical outcomes in patients with obstructive hypertrophic cardiomyopathy.

In a remarkable display of expertise and advanced cardiac care, KMC Hospital, Dr B R Ambedkar Circle successfully treated Fr Wolfgang Leonhard, a 65-year-old German national, who was rushed to the ...

KMC Hospital in Mangaluru successfully treats Rev Fr Wolfgang Leonhard, a German priest, diagnosed with hypertrophic obstructive cardiomyopathy and complete heart block. The cardiology team implanted ...

Silicone scar tape provides a noninvasive approach to scar treatment, improving outcomes for hypertrophic and keloid scars through hydration and occlusion.

Rolling Submission of NDA for Aficamten Completed and Submitted to FDA in Q3 COMET-HF, Confirmatory Phase 3 Clinical Trial of ...

Hypertrophic cardiomyopathy (HCM ... and the most appropriate investigations for persons suspected of having HCM. Treatment strategies for the disease and its complications are presented briefly.

The San Francisco-based drugmaker recently launched a campaign to educate healthcare professionals (HCP) about hypertrophic ...

View the full release here: "We are honored to be recognized with the Prix Galien Award for Best Digital Health Solution," ...

A 10 year-old boy in Pottsboro, TX is awaiting a heart transplant at the Dallas Children’s Hospital following a phone call ...

Death is a daunting prospect for many, but after a lot of reflection and work on herself, Bella Salsberry feels at peace with the life she's been granted.

The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with preserved ejection fraction; TP-03 for the treatment of Demodex ...

Analyst Michael Ulz of Morgan Stanley maintained a Buy rating on Tenaya Therapeutics (TNYA – Research Report), retaining the price target ...